TickerFactsScreenerDevelopers

AIM ImmunoTech Inc. (AIM) — Revenue

Annual figures by fiscal year, from SEC filings.

2009: $111.0K2010: $135.0K2011: $161.0K2012: $213.0K2013: $150.0K2014: $197.0K2017: $437.0K2018: $367.0K2022: $141.0K2023: $202.0K2024: $170.0K2025: $88.0K$88.0K
2009Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$88.0K-48.2%
2024$170.0K-15.8%
2023$202.0K+43.3%
2022$141.0K—
2018$367.0K-16.0%
2017$437.0K—
2014$197.0K+31.3%
2013$150.0K-29.6%
2012$213.0K+32.3%
2011$161.0K+19.3%
2010$135.0K+21.6%
2009$111.0K—